In this study, we found that the increase in Sp1 degradation in premenopausal women with lung cancer can inhibit Sp1-mediated miRNA expression, thus activating EMT-related gene expression and leading to lung cancer malignancy. The gene discussed is SP1; the disease is lung carcinoma.